Members |
targetComponentId |
Annual |
Annual |
Annuloplasty - action |
Reconstruction - action |
ASRT-testet (Anomalous sentence repetition test - Weeks) |
Anomalous sentences repetition test |
Anosmic aphasia |
Anomic aphasia |
Anser caerulescens |
Chen caerulescens (organism) |
Anser caerulescens caerulescens |
Chen caerulescens caerulescens (organism) |
överdos av disulfiram |
Disulfiram overdose (disorder) |
förgiftning orsakad av disulfiram |
Disulfiram poisoning (disorder) |
Antazoline sulfate+xylometazoline hydrochloride |
Product containing antazoline and xylometazoline (medicinal product) |
prenatal anti-D-profylax avböjd |
Administration of RhD immune globulin declined |
Antenatal blood group screening NOS |
Antenatal blood group screening status |
Antenatal blood group screening NOS |
Antenatal blood group screening status |
prenatal korionvillibiopsi avböjd |
Sampling of chorionic villus declined |
prenatal blodscreening avseende hepatit B avböjd |
Antenatal screening for viral hepatitis type B declined |
prenatal blodscreening avseende HIV avböjd |
Antenatal screening for human immunodeficiency virus declined (situation) |
Antenatal scan unable to confirm pregnancy |
Antenatal scan unable to confirm pregnancy (finding) |
prenatal blodscreening avseende talassemi avböjd |
Antenatal thalassemia screening declined (situation) |
Antenatal ultrasound confirms ectopic pregnancy |
Antenatal ultrasound confirms ectopic pregnancy (finding) |
Antenatal ultrasound confirms intrauterine pregnancy |
Antenatal ultrasound confirms intrauterine pregnancy (finding) |
blödning ante partum orsakad av disseminerad intravasal koagulation |
Antepartum hemorrhage with disseminated intravascular coagulation (disorder) |
Anterior cervical cord injury, without bony injury, C1-4 |
Anterior cervical spinal cord injury at C1-C4 level without spinal bone injury |
Anterior cervical cord injury, without bony injury, C5-7 |
Anterior cervical spinal cord injury, without spinal bone injury, C5-7 (disorder) |
Antheorfilter för temporärt bruk |
Temporary vena cava filter |
antralin 0,2 %, kräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
antralin 0,2 %, hudkräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
antralin 0,4 %, kräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
antralin 0,4 %, hudkräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
färg innehållande antrakinon |
Anthraquinone |
immunglobulin anti-D (Rh) 1 250 IE/ml, injektionsvätska, lösning, förfyllld spruta 1 ml |
Human anti-D immunoglobulin 1250 unit/mL solution for injection |
immunglobulin anti-D (Rh) 1 500 IE, pulver och vätska till injektionslösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 1 500 IE, pulver till injektionsvätska, lösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 2 500 IE, injektionsvätska, lösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 250 IE, injektionsvätska, lösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 5 000 IE, injektionsvätska, lösning, flaska |
Blood group antibody D 1136 unit/mL solution for injection |
immunglobulin anti-D (Rh) 5 000 IE, pulver och vätska till injektionslösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 5 000 IE, pulver till injektionsvätska, lösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 500 IE, injektionsvätska, lösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 600 IE, pulver och vätska till injektionslösning, flaska |
Blood group antibody D only product in parenteral dose form |
immunglobulin anti-D (Rh) 600 IE, pulver till injektionsvätska, lösning, flaska |
Blood group antibody D only product in parenteral dose form |
Anti-endomysium antibody |
Endomysial antibody |
Anti-gliadin antibody |
Gliadin antibody |
medel mot gikt |
Uricosuric agent |
Antianaemic agent |
Medicinal product acting as antianemic agent (product) |
Antibiotic |
Medicinal product acting as antibacterial agent (product) |
antibiotiska medel mot tuberkulos |
Antituberculosis agent |
biverkning av antibiotiskt medel mot tuberkulos |
Antituberculous drug adverse reaction |
Antibody by type |
Antibody |
Anticardiolipin antibody |
Cardiolipin antibody |
Anticoagulant therapy |
Administration of anticoagulant |
Antidiabetic agent preparation |
Medicinal product acting as antidiabetic agent (product) |
Antiepileptics |
Medicinal product acting as anticonvulsant agent (product) |
Antigen to antibody in Kell blood group system |
Antibody to antigen in Kell blood group system (substance) |
behandlingsfunktion mot gikt |
Uricosuric therapeutic role |
antihemofilifaktorpreparat 1 000 IE, pulver till injektionsvätska, lösning, flaska |
Antihemophilic factor agent only product |
antihemofilifaktorpreparat, 1 000 IE, pulver till injektionsvätska, lösning, flaska 5 ml + spädningsvätska |
Antihemophilic factor agent only product |
antihemofilifaktorpreparat 1 500 IE, pulver till injektionsvätska, lösning, flaska |
Antihemophilic factor agent only product |
antihemofilifaktorpreparat, 1 500 IE, pulver till injektionsvätska, flaska 5 ml + spädningsvätska |
Antihemophilic factor agent only product |
antihemofilifaktorpreparat 500 IE, pulver till injektionsvätska, lösning, flaska |
Antihemophilic factor agent only product |
antihemofilifaktorpreparat, 500 IE, pulver till injektionsvätska, flaska 5 ml + spädningsvätska |
Antihemophilic factor agent only product |
Antimongolism syndrome |
Deletion of part of autosome |
cytostatikum innehållande alkaloid |
Alkaloid (substance) |
Antineoplastic or immunosuppressive |
Antineoplastic agent |
Antiphlogistic agent |
Medicinal product acting as antiinflammatory agent (product) |
trombocythämmande behandlingsfunktion |
Therapeutic role (role) |
Antipyrine + benzocaine + glycerin 54mg/14mg/1cc solution |
Product containing only benzocaine and phenazone (medicinal product) |
fenazon 5,4 vikt/volymprocent + bensokain 1,442 vikt/volymprocent, lösning |
Product containing only benzocaine and phenazone (medicinal product) |
Antithrombin I |
Fibrin |
Antithrombin II |
Fibrin |
Antithrombin IV |
Fibrin |
Antituberculosis AND/OR antileprosy agent |
Substance with antimycobacterial mechanism of action (substance) |
Anus problem |
Anal symptoms |
Aphthovirus 0 |
Foot-and-mouth disease virus O (organism) |
Aphthovirus Asia 1 |
Foot-and-mouth disease virus Asia 1 (organism) |
Aphthovirus SAT 1 |
Foot-and-mouth disease virus SAT 1 (organism) |
Aphthovirus SAT 2 |
Foot-and-mouth disease virus SAT 2 (organism) |
Aphthovirus SAT 3 |
Foot-and-mouth disease virus SAT 3 (organism) |
Apis |
Bee |
Apomorphine hydrochloride [erectile dysfunction] |
Product containing apomorphine (medicinal product) |
gastrisk ballong för aptitminskning |
Gastric balloon |
äpple, livsmedel |
Apple (substance) |
Appliances+equipment |
Appliance |
Application of sling by nursing personnel |
Application of sling |
applicering av sterzacpuder på navelstump |
Application of hexachlorophene powder to umbilical cord stump (procedure) |
Application of traction |
Traction |
tillvägagångssätt |
Surgical approach (attribute) |
Approximate relative activity of corticosteroids |
Medicinal product acting as antiinflammatory agent (product) |
apraklonidin 1 %, lösning för intraokulär användning |
Apraclonidine (as apraclonidine hydrochloride) 10 mg/mL eye solution |
Apraclonidine hydrochloride 1%/mL solution |
Apraclonidine (as apraclonidine hydrochloride) 10 mg/mL eye solution |
aprikos, livsmedel |
Apricot (substance) |
aprotinin 10 000 IE/ml, injektionsvätska, lösning, flaska 50 ml |
Aprotinin 1.4 mg/mL solution for injection |
aprotinin 10 000 kE/ml, injektionsvätska, lösning, flaska 100 ml |
Product containing only aprotinin in parenteral dose form (medicinal product form) |
Aprotinin injection |
Product containing only aprotinin in parenteral dose form (medicinal product form) |
Aprotinin injection 10mL |
Aprotinin 1.4 mg/mL solution for injection |
Aprotinin injection 10mL |
Aprotinin 1.4 mg/mL solution for injection |
Aprotinin injection 5mL |
Aprotinin 1.4 mg/mL solution for injection |
Aquila heliaca adalberti |
Aquila adalberti (organism) |
Ara auricollis |
Primolius auricollis (organism) |
Ara couloni |
Primolius couloni (organism) |
Ara manilata |
Orthopsittaca manilata (organism) |
Ara maracana |
Primolius maracana (organism) |
Ara nobilis |
Diopsittaca nobilis (organism) |